ASCP Board of Directors Announces Leadership Transition as CEO Dr. E. Blair Holladay Prepares for Retirement

The Board of Directors of the American Society for Clinical Pathology (ASCP) announces that E. Blair Holladay, PhD, MASCP, SCT(ASCP)^CM, is retiring as Chief Executive Officer, concluding a remarkable 20-year career with the organization.

Throughout his tenure, Dr. Holladay has partnered with ASCP volunteer leaders in a period of exceptional growth and impact. During his time, the organization has expanded access to diagnostics worldwide, built influential partnerships with healthcare and policy leaders, and strengthened its role as a global authority in pathology and laboratory medicine. His efforts have placed pathologists and laboratory professionals at the forefront of patient care and health system transformation.

Prior to serving as CEO for 15 years, Dr. Holladay held the role of Executive Director of the ASCP Board of Certification for 5 years, where he was instrumental in advancing certification processes and expanding global outreach. Across all of his roles, he has championed innovation, equity in healthcare, and the advancement of the laboratory workforce.

The ASCP Board of Directors has appointed Alexandra Brown, MD, FASCP, ASCP Chief Medical Officer, as Interim CEO beginning August 1, 2025. Dr. Brown’s longstanding involvement with ASCP began well before she joined the staff, having served as a dedicated volunteer in several leadership roles—including Chair of the Resident Council and Chair of the Pathologist (Fellow) Council. In 2016, she joined ASCP as Chief Officer, Medical Quality, and in 2023 was appointed Chief Medical Officer, playing a key role in shaping and supporting many of ASCP’s strategic initiatives. 

Dr. Brown’s deep clinical expertise and unwavering commitment to ASCP’s patient-centered mission position her well to guide the organization through this important period of transition. A formal search committee is being convened by the Board of Directors to lead the process of selecting a permanent Chief Executive Officer.

ASCP remains steadfast in its mission to provide excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals in the United States and around the world. We extend our sincere gratitude to Dr. Holladay for his visionary leadership and years of dedicated service, and we look forward to the continued strength and stability of ASCP under Dr. Brown’s interim leadership.